Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: Results from the study of heart and renal protection by Reith, C, Staplin, N, Herrington, W, Stevens, W, Emberson, J, Haynes, R, Mafham, M, Armitage, J, Cass, A, Craig, J, Jiang, L, Pedersen, T, Baigent, C, Landray, M, on behalf of the SHARP Collaborative Group

Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection by C. Reith, N. Staplin, W. G. Herrington, W. Stevens, J. Emberson, R. Haynes, M. Mafham, J. Armitage, A. Cass, J. C. Craig, L. Jiang, T. Pedersen, C. Baigent, M. J. Landray, on behalf of the SHARP Collaborative Group

Get full text

Smoking and adverse outcomes in patients With CKD: the Study of Heart and Renal Protection (SHARP) by Emberson, J, Staplin, N, Haynes, R, Herrington, W, Reith, C, Landray, M, Baigent, C, Cass, A, Fellström, B, Jiang, L, Kasiske, B, Krane, V, Levin, A, Walker, R, Wanner, C, Wheeler, D, SHARP Collaborative Group

Prognostic utility of estimated albumin excretion rate in chronic kidney disease: results from the Study of Heart and Renal Protection. by Mafham, M, Staplin, N, Emberson, J, Haynes, R, Herrington, W, Reith, C, Wanner, C, Walker, R, Cass, A, Levin, A, Fellström, B, Jiang, L, Holdaas, H, Kasiske, B, Wheeler, D, Landray, M, Baigent, C, SHARP Collaborative Group

Impact of outcome adjudication in kidney disease trials: observations from the Study of Heart and Renal Protection (SHARP) by Herrington, WG, Harper, C, Staplin, N, Haynes, R, Emberson, J, Reith, C, Hooi, LS, Levin, A, Wanner, C, Baigent, C, Landray, M

Other Authors: “…SHARP Collaborative Group…”